Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Efficacy and Safety of Indomethacin in Covid-19 patients

Rajan Ravichandran, Prassana Purna, Sivakumar Vijayaragavan, Ravi Teja Kalavakollu, Shilpa Gaidhane, Ramarathnam Krishna Kumar
doi: https://doi.org/10.1101/2020.12.14.20245266
Rajan Ravichandran
aDepartment of Nephrology, MIOT International, Chennai, India and Adjunct Faculty Indian Institute of Technology Madras, Chennai India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prassana Purna
bDepartment of Pulmonology, Narayana Medical College, Nellore, Andhra Pradesh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sivakumar Vijayaragavan
cNarayana Translational Research Centre, Narayana Medical College, Nellore, Andhra Pradesh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravi Teja Kalavakollu
bDepartment of Pulmonology, Narayana Medical College, Nellore, Andhra Pradesh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shilpa Gaidhane
dDepartment of Medicine, Datta Meghe Institute of Medical Science, Wardha, Maharashtra, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramarathnam Krishna Kumar
eDepartment of Engineering Design, Indian Institute of Technology Madras, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rkkumar@iitm.ac.in
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2020.12.14.20245266
History 
  • December 16, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Rajan Ravichandrana,
  2. Prassana Purnab,
  3. Sivakumar Vijayaragavanc,
  4. Ravi Teja Kalavakollub,
  5. Shilpa Gaidhaned and
  6. Ramarathnam Krishna Kumare,1
  1. aDepartment of Nephrology, MIOT International, Chennai, India and Adjunct Faculty Indian Institute of Technology Madras, Chennai India
  2. bDepartment of Pulmonology, Narayana Medical College, Nellore, Andhra Pradesh, India
  3. cNarayana Translational Research Centre, Narayana Medical College, Nellore, Andhra Pradesh, India
  4. dDepartment of Medicine, Datta Meghe Institute of Medical Science, Wardha, Maharashtra, India
  5. eDepartment of Engineering Design, Indian Institute of Technology Madras, Chennai, India
  1. ↵1Corresponding author. Email: rkkumar{at}iitm.ac.in
Back to top
PreviousNext
Posted December 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy and Safety of Indomethacin in Covid-19 patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy and Safety of Indomethacin in Covid-19 patients
Rajan Ravichandran, Prassana Purna, Sivakumar Vijayaragavan, Ravi Teja Kalavakollu, Shilpa Gaidhane, Ramarathnam Krishna Kumar
medRxiv 2020.12.14.20245266; doi: https://doi.org/10.1101/2020.12.14.20245266
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Efficacy and Safety of Indomethacin in Covid-19 patients
Rajan Ravichandran, Prassana Purna, Sivakumar Vijayaragavan, Ravi Teja Kalavakollu, Shilpa Gaidhane, Ramarathnam Krishna Kumar
medRxiv 2020.12.14.20245266; doi: https://doi.org/10.1101/2020.12.14.20245266

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (433)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (420)
  • Epidemiology (8982)
  • Forensic Medicine (4)
  • Gastroenterology (419)
  • Genetic and Genomic Medicine (1949)
  • Geriatric Medicine (190)
  • Health Economics (401)
  • Health Informatics (1328)
  • Health Policy (659)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10800)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1825)
  • Nursing (109)
  • Nutrition (272)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (997)
  • Ophthalmology (297)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (579)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1896)
  • Public and Global Health (4120)
  • Radiology and Imaging (675)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (80)